These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 9065133)

  • 1. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone.
    Kutteh WH
    Am J Obstet Gynecol; 1996 May; 174(5):1584-9. PubMed ID: 9065133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-molecular-weight heparin versus intravenous immunoglobulin for recurrent abortion associated with antiphospholipid antibody syndrome.
    Dendrinos S; Sakkas E; Makrakis E
    Int J Gynaecol Obstet; 2009 Mar; 104(3):223-5. PubMed ID: 19116178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinical trial for the treatment of antiphospholipid antibody-associated recurrent pregnancy loss with lower dose heparin and aspirin.
    Kutteh WH; Ermel LD
    Am J Reprod Immunol; 1996 Apr; 35(4):402-7. PubMed ID: 8739461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin.
    Backos M; Rai R; Baxter N; Chilcott IT; Cohen H; Regan L
    Br J Obstet Gynaecol; 1999 Feb; 106(2):102-7. PubMed ID: 10426674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiphospholipid antibody syndrome.
    Kutteh WH; Hinote CD
    Obstet Gynecol Clin North Am; 2014 Mar; 41(1):113-32. PubMed ID: 24491987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin or heparin or both in the treatment of recurrent spontaneous abortion in women with antiphospholipid antibody syndrome: a meta-analysis of randomized controlled trials.
    Lu C; Liu Y; Jiang HL
    J Matern Fetal Neonatal Med; 2019 Apr; 32(8):1299-1311. PubMed ID: 29179589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment outcome in women suffering from recurrent miscarriages and antiphospholipid syndrome].
    Malinowski A; Dyński MA; Maciołek-Blewniewska G; Głowacka E; Pawłowski T; Babula G
    Ginekol Pol; 2003 Oct; 74(10):1213-22. PubMed ID: 14669420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregnancy outcome in women with antiphospholipid syndrome on low-dose aspirin and heparin: a retrospective study.
    Naru T; Khan RS; Ali R
    East Mediterr Health J; 2010 Mar; 16(3):308-12. PubMed ID: 20795446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enoxaparin versus unfractionated heparin in the management of recurrent abortion secondary to antiphospholipid syndrome.
    Fouda UM; Sayed AM; Abdou AM; Ramadan DI; Fouda IM; Zaki MM
    Int J Gynaecol Obstet; 2011 Mar; 112(3):211-5. PubMed ID: 21251653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies).
    Rai R; Cohen H; Dave M; Regan L
    BMJ; 1997 Jan; 314(7076):253-7. PubMed ID: 9022487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of thrombosis and pregnancy loss in the antiphospholipid syndrome.
    Khamashta MA
    Lupus; 1998; 7 Suppl 2():S162-5. PubMed ID: 9814696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials.
    Empson M; Lassere M; Craig JC; Scott JR
    Obstet Gynecol; 2002 Jan; 99(1):135-44. PubMed ID: 11777524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies.
    Triolo G; Ferrante A; Ciccia F; Accardo-Palumbo A; Perino A; Castelli A; Giarratano A; Licata G
    Arthritis Rheum; 2003 Mar; 48(3):728-31. PubMed ID: 12632426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment.
    Cowchock FS; Reece EA; Balaban D; Branch DW; Plouffe L
    Am J Obstet Gynecol; 1992 May; 166(5):1318-23. PubMed ID: 1595785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin or aspirin or both in the treatment of recurrent abortions in women with antiphospholipid antibody (syndrome).
    Hoppe B; Burmester GR; Dörner T
    Curr Opin Rheumatol; 2011 May; 23(3):299-304. PubMed ID: 21346577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression.
    Mak A; Cheung MW; Cheak AA; Ho RC
    Rheumatology (Oxford); 2010 Feb; 49(2):281-8. PubMed ID: 19965971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Obstetrical APS: Is there a place for additional treatment to aspirin-heparin combination?].
    Mekinian A; Kayem G; Cohen J; Carbillon L; Abisror N; Josselin-Mahr L; Bornes M; Fain O
    Gynecol Obstet Fertil Senol; 2017 Jan; 45(1):37-42. PubMed ID: 28238314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin.
    Noble LS; Kutteh WH; Lashey N; Franklin RD; Herrada J
    Fertil Steril; 2005 Mar; 83(3):684-90. PubMed ID: 15749498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiphospholipid antibodies (APA) and recurrent pregnancy loss: treating a unique APA positive population.
    Franklin RD; Kutteh WH
    Hum Reprod; 2002 Nov; 17(11):2981-5. PubMed ID: 12407061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two therapeutic protocols in patients with antiphospholipid antibodies and recurrent miscarriages.
    Jeremić K; Pervulov M; Gojnić M; Dukanac J; Ljubić A; Stojnić J
    Vojnosanit Pregl; 2005 Jun; 62(6):435-9. PubMed ID: 16047856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.